Recent Finacing
Recent Raise
Day One Biopharma is a clinical-stage drug developer focused on pediatric and adult cancers, advancing DAY101, an oral brain-penetrant type II pan‑RAF inhibitor, in trials for RAF‑altered tumors.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Day One Biopharmaceuticals.
